Navigation Links
Stem Cell Sciences Announces the Creation of the World's First Authentic Rat Embryonic Stem Cells from its Exclusively Licensed Technology
Date:9/2/2008

CAMBRIDGE, England, September 2 /PRNewswire-FirstCall/ --

- ("Stem Cell Sciences", "SCS", "the Company")

Stem Cell Sciences plc (AIM:STEM, ASX:STC), a company focused on the commercialisation of stem cells and stem cell technologies, is pleased to announce that two independent laboratories in the UK and USA have achieved germ-line transmission from embryonic stem (ES) cells in rats using technologies exclusively licensed to the company by Edinburgh University. This is believed to be the first time that germ-line transmission from rat ES cells has been demonstrated, and full scientific reports on this breakthrough, which has been independently verified, have been submitted to a major scientific journal for publication.

Under the terms of its agreement with Edinburgh University, SCS has global exclusive rights to commercialise the rat ES cells, the specific culture medium used to generate and grow the cells, and rats derived therefrom. The Company has exclusively licensed two important patents covering this new technology from the University and now plans to engage in confidential discussions with interested parties seeking a sublicence to use rat ES cells in their commercial drug discovery programmes.

The main advantage of this important new technology is that it allows the generation of both knock-out rat models, in which the effect of gene deletion is studied, as well as the generation of knock-in models, which involves the insertion of genes. For example, in the case of knock-out models, their response to drugs can provide information on safety and efficacy. Alternatively, the insertion of genes such as those involved in drug metabolism in the human liver means that knock-in models can provide information on human safety and pharmacokinetics.

"This remarkable breakthrough will enable the generation of transgenic rat models for drug discovery in a very similar manner to the already widely used transgenic mice models. The ad
'/>"/>

SOURCE Stem Cell Sciences plc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Neurosciences Institute Discovers Drug Extends Stroke Treatment Time to 24 Hours, Repairs Brain Tissue
2. Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial
3. Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer
4. Ardea Biosciences Advances Lead Product Candidate for the Treatment of Gout, RDEA594, Into Phase 1 Clinical Trial
5. Particle Sciences Expands Its Combination Product Capabilities
6. Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference
7. Light Sciences Oncology Raises $40.1 Million in Series C Financing
8. Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
9. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
10. Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
11. Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...LAND, Calif., Nov. 6 Kaiser Founda...s (KFHP/H), and their subsidiaries reported today ...n for the quarter ended September 30, 2009, compar...ear. Operating income in the third quarter was $33...uarter of last year. Net non-operating income was ...
(Date:11/6/2009)...ROIT, Nov. 6 Caraco Phar...as launched ketorolac tromethamine ophthalmic solu...Food and Drug Administration (FDA) for Sun Pharma,...ric Acular® ophthalmic solution on the first ...ketorolac is therapeutically equivalent to Acular&...
(Date:11/6/2009)...NCETON, N.J., Nov. 6 D...a provider of advanced wound care products, announ...s before market on Monday, November 16, 2009. The ...to discuss the results at 11:00 am EST. Interested...(857) 350-1684 (international), with passcode 8141...
Breaking Medicine Technology:Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 2Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 4Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2AstraZeneca Submits New Drug Applications for ZACTIMA 28TM 29 in Second Line Advanced Non Small Cell Lung Cancer 53204 1AstraZeneca Submits New Drug Applications for ZACTIMA 28TM 29 in Second Line Advanced Non Small Cell Lung Cancer 53204 2AstraZeneca Submits New Drug Applications for ZACTIMA 28TM 29 in Second Line Advanced Non Small Cell Lung Cancer 53204 3AstraZeneca Submits New Drug Applications for ZACTIMA 28TM 29 in Second Line Advanced Non Small Cell Lung Cancer 53204 4Sunesis Receives Approval for Listing on The NASDAQ Capital Market 13280 1Sunesis Receives Approval for Listing on The NASDAQ Capital Market 13280 2Sunesis Receives Approval for Listing on The NASDAQ Capital Market 13280 3Lotus Pharmaceuticals Inc Announces Patent Pending Gliclazide Controlled Release Tablets 13278 1Lotus Pharmaceuticals Inc Announces Patent Pending Gliclazide Controlled Release Tablets 13278 2Lotus Pharmaceuticals Inc Announces Patent Pending Gliclazide Controlled Release Tablets 13278 3
(Date:11/9/2009)..., MAYWOOD, Il. -- Gifted young athletes are und... round. , But a new Loyola University Health Sys...hat such specialization increases the risk of inju...ed States Tennis Association junior competition fo...re more likely to withdraw from tournaments for me...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 ...ssued the following statement about the passage of...s and the American voters a lot about core values....core values, seeking to overcome the struggles ord...gles mean that many cannot afford basic healthcare...
(Date:11/8/2009)...traight-back, chest-out position promotes self-ass...8 (HealthDay News) -- Your mother may have been ri...arch suggests that good posture could make you fee...of us were taught that sitting up straight gives a...co-author of the study and a psychology professor ...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 ...a press conference following the House passage of ...Act. The bill passed by a vote of 220 to 215. Be...nd some of my colleagues just received a call from... congratulating us on a great victory for the Amer...
(Date:11/8/2009)... Freeze-drying of biopharm...Mississauga, Ontario facility. , ...homas Wellner, President and CEO of Therapure Biop...ken delivery of a commercial scale pharmaceutical ...scale freeze drying (lyophilization) available for...
Breaking Medicine News(10 mins):Health News:Young tennis players who play only 1 sport are more prone to injuries 2Health News:Catholics for Choice Statement on Healthcare Reform Bill 2Health News:Good Posture May Inspire Confidence 2Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2
...ally common after the death of a spouse , ... keep up active social lives as they age may be do...ng socially active may increase feelings of self-w...llenges, keeping the brain more agile. , "We asses...
...sing Home Care Slashed,$3.7 Million in Year Ahead;...o Publicly Oppose Cuts to Seniors, Medicare Fundin...ck in Minnesota this week for the Memorial Day dis...nistration,s,planned regulatory cuts to seniors, M...
... not like,re-engineering -- they focus on incremen...hese increments can grow to be quite large --,comp...n savings of $1.2,million from their largest-impac...www3.best-in-class.com/dr308.htm ., Quality leade...
...ance to Workers, ERIE, Pa., May 29 Governor Edwa...d adults in Erie County -- many of whom,who work f...a waiting list,to receive health care coverage -- ...ce would also,benefit from the plan,s $42 million ...
...dvanced fibrosis have twice the risk of developing...ndings are published in the June issue of Hepatolo...half of the American Association for the Study of ...hat diabetes increases ones risk for hepatocellula...
...s -, MISSISSAUGA, ON, May 29 /PRNewswire-FirstCal...g development company focused on the research and,...ugh the skin using its,topical and transdermal dru...vel topical pain formulation with the,potential to...
Other Medicine News:Health News:Active Social Life Helps Keep Aging Mind Sharp 2Health News:Active Social Life Helps Keep Aging Mind Sharp 3Health News:Minnesota, National Long Term Care Advocates: Pending Bush Medicare Cut Hurts State's Rural Seniors 2Health News:Minnesota, National Long Term Care Advocates: Pending Bush Medicare Cut Hurts State's Rural Seniors 3Health News:Minnesota, National Long Term Care Advocates: Pending Bush Medicare Cut Hurts State's Rural Seniors 4Health News:Governor Rendell Says PA ABC Will Help Low-Wage Small Businesses Pay for Employee Health Coverage 2Health News:Governor Rendell Says PA ABC Will Help Low-Wage Small Businesses Pay for Employee Health Coverage 3Health News:Governor Rendell Says PA ABC Will Help Low-Wage Small Businesses Pay for Employee Health Coverage 4Health News:Diabetes doubles liver cancer risk for patients with advanced hepatitis C 2Health News:Nuvo licenses topical pain product from Paladin 2Health News:Nuvo licenses topical pain product from Paladin 3
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: